Serum soluble α-Klotho levels in patients with diabetic nephropathy

被引:4
|
作者
Lefta, Rami Fadhel [1 ]
Hassan, Ekhlas Abdallah [1 ]
机构
[1] Univ Diyala, Dept Chem, Coll Sci, Baquba, Diyala, Iraq
关键词
ACR; alpha-Klotho; Diabetic nephropathy; HOMA-IR; SECRETED KLOTHO; KIDNEY-FUNCTION; GLUCOSE;
D O I
10.1007/s11845-023-03502-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The study aimed to determine the variability in the stages of diabetic nephropathy by examining specific biochemical functions associated with the target organ. As a result, various biochemical parameters were assessed in all of the groups under investigation. Material and methods These parameters encompassed soluble alpha-Klotho and serum insulin, which were determined through ELISA. Additionally, spectrophotometric methods were employed to assess other parameters such as blood levels of urea in all groups. Instead of using HPLC method, HbA1c levels were determined. Blood and urine samples were obtained from a total of 90 participants, who were aged between 37 and 70 years. A total of 70 patients were categorized into three groups according to their ACR. The first group consisted of patients with an ACR value of less than 30 mg/g. The second group included patients with an ACR value ranging from 30 to 300 mg/g. The third group comprised patients with an ACR value greater than 300 mg. Additionally, the study also involved 20 healthy individuals. Result The serum soluble alpha-Klotho in the patient group was significantly lower than that of the healthy subjects. There were strong negative correlations between serum soluble alpha-Klotho and both ACR and HOMA-IR. The AUC value was excellent, measuring at 0.93 with a p < 0.0001. Conclusions Soluble alpha-Klotho levels in the sera of diabetic patients were shown to be lower and significantly linked to patients with diabetic nephropathy. This implies that klotho levels may be influenced by ACR in addition to playing a significant role in insulin resistance.
引用
收藏
页码:725 / 731
页数:7
相关论文
共 50 条
  • [21] Effects of cinacalcet treatment on serum soluble Klotho levels in haemodialysis patients with secondary hyperparathyroidism
    Komaba, Hirotaka
    Koizumi, Masahiro
    Tanaka, Hisae
    Takahashi, Hiroo
    Sawada, Kaichiro
    Kakuta, Takatoshi
    Fukagawa, Masafumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) : 1967 - 1969
  • [22] High serum soluble -Klotho levels in patients with autosomal dominant polycystic kidney disease
    Sari, Funda
    Inci, Ayca
    Dolu, Suleyman
    Ellidag, Hamit Yasar
    Cetinkaya, Ramazan
    Ersoy, Fettah Fevzi
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 358 - 362
  • [23] Serum soluble alpha klotho and periostin as a biomarker for detection of early diabetic nephropathy in Iraqi male with Type 2 Diabetes
    Al-temimi, Refaa B.
    Abdulla, Amer Hasan
    Tahir, Noor
    JOURNAL OF RESEARCH IN PHARMACY, 2024, 28 (05): : 1665 - 1673
  • [24] THE IMPACT OF NEPHRECTOMY ON THE SERUM AND URINE LEVELS OF SOLUBLE KLOTHO PROTEIN
    Kimura, Takaaki
    Akimoto, Tetsu
    Nanmoku, Koji
    Kurosawa, Akira
    Shimizu, Toshihiro
    Muto, Shigeaki
    Nagata, Saisuke
    Yagisawa, Takashi
    TRANSPLANT INTERNATIONAL, 2015, 28 : 505 - 505
  • [25] DETECTION OF SERUM COPEPTIN LEVELS IN DIABETIC PATIENTS TO EVALUATE PROGRESSIVE NEPHROPATHY
    Noor, Tooba
    Khan, Muhammad Tassaduq
    Hanif, Farina
    Kiran, Zareen
    Baloch, Akhtar Ali
    Rehman, Rehana
    NEPHROLOGY, 2020, 25 : 39 - 39
  • [26] ELEVATION OF SERUM IGA1 LEVELS IN PATIENTS WITH DIABETIC NEPHROPATHY
    OHMURO, H
    TOMINO, Y
    TSUSHIMA, Y
    SHIMIZU, M
    KURAMOTO, T
    KOIDE, H
    NEPHRON, 1993, 63 (03): : 355 - 355
  • [27] Serum prolactin and macroprolactin levels in diabetic nephropathy
    Sari, Funda
    Sari, Ramazan
    Ozdem, Sebahat
    Sarikaya, Metin
    Cetinkaya, Ramazan
    CLINICAL NEPHROLOGY, 2012, 78 (01) : 33 - 39
  • [28] Evaluation of serum adiponectin levels in diabetic nephropathy
    Alnaggar, Alshaimaa Rezk L. R.
    Sayed, Mohamed
    El-deena, Kareem Essam
    Gomaa, Mohamed
    Hamed, Yousra
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 128 - 131
  • [29] Increased levels of soluble Fas in serum from diabetic patients with neuropathy
    Guillot, R
    Bringuier, AF
    Porokhov, B
    Guillausseau, PJ
    Feldmann, G
    DIABETES & METABOLISM, 2001, 27 (03) : 315 - 321
  • [30] Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy
    Emara, Asmaa Mounir
    El Bendary, Amal Said
    Ahmed, Laila Mahmoud
    Okda, Hanaa Ibrahim
    BMC NEPHROLOGY, 2024, 25 (01)